Jacqueline Renee Kulbe

Jacqueline Renee Kulbe

Auto-generated profile, based on publicly available information

Jacqueline Renee Kulbe

University of California, San Diego Department of Psychiatry, San Diego, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Experimental Neurology
Verified
Journal Article
Closed access
JKJacqueline R. Kulbe
Jacqueline R. Kulbe
JGJames W. Geddes
James W. Geddes

1 January 2014 in Brain Research
Verified
Journal Article
Closed access
JKJacqueline R. Kulbe
Jacqueline R. Kulbe
JLJean M. Mulcahy Levy
Jean M. Mulcahy Levy
SCSteven J. Coultrap
Steven J. Coultrap
ATAndrew Thorburn
Andrew Thorburn
KBK. Ulrich Bayer
K. Ulrich Bayer

19 May 2014 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
KBKelsey Barcomb
Kelsey Barcomb
IBIsabelle Buard
Isabelle Buard
SCSteven J. Coultrap
Steven J. Coultrap
JKJacqueline R. Kulbe
Jacqueline R. Kulbe
HOHeather O'LEary
Heather O'LEary
KBK. Ulrich Bayer
K. Ulrich Bayer
A hallmark feature of Ca 2+ /calmodulin (CaM)‐dependent protein kinase II (CaMKII) is generation of autonomous (Ca 2+ ‐independent) activity by T286 autophosphorylation. Biochemical studies have shown that “autonomous” CaMKII is ~5‐fold further stimulated by Ca 2+ /CaM, but demonstration of a physiological function for such regulation within cells has remained elusive. In this study, CaMKII‐induced enhancement of synaptic strength in rat hippocampal neurons required both autonomous activity and further stimulation. Synaptic strength was decreased by CaMKIIα knockdown and rescued by reexpression, but not by mutants impaired for autonomy (T286A) or binding to NMDA‐type glutamate receptor subunit 2B (GluN2B; formerly NR2B; I205K). Full rescue was seen with constitutively autonomous mutants (T286D), but only if they could be further stimulated (additional T305/306A mutation), and not with two other mutations that additionally impair Ca 2+ /CaM binding. Compared to rescue with wild‐type CaMKII, the CaM‐binding‐impaired mutants even had reduced synaptic strength. One of these mutants (T305/306D) mimicked an inhibitory autophosphorylation of CaMKII, whereas the other one (Δstim) abolished CaM binding without introducing charged residues. Inhibitory T305/306 autophosphorylation also reduced GluN2B binding, but this effect was independent of reduced Ca 2+ /CaM binding and was not mimicked by T305/306D mutation. Thus, even autonomous CaMKII activity must be further stimulated by Ca 2+ /CaM for enhancement of synaptic strength.—Barcomb, K., Buard, I., Coultrap, S. J., Kulbe, J. R., O'Leary, H., Benke, T. A., Bayer, K. U. Autonomous CaMKII requires further stimulation by Ca 2+ /calmodulin for enhancing synaptic strength. FASEB J. 28, 3810–3819 (2014). www.fasebj.org

6 October 2023 in Journal of NeuroVirology
Verified
Journal Article
Open access
PDF file
JKJacqueline Renee Kulbe
Jacqueline Renee Kulbe
ALAlexandra Anh Le
Alexandra Anh Le
MMMichael Mante
Michael Mante
JFJazmin Florio
Jazmin Florio
ALAnna Elizabeth Laird
Anna Elizabeth Laird
Jerel A FieldsJerel A Fields
Jerel A Fields
Central nervous system (CNS) dysfunction remains prevalent in people with HIV (PWH) despite effective antiretroviral therapy (ART). There is evidence that low-level HIV infection and ART drugs may contribute to CNS damage in the brain of PWH with suppressed viral loads. As cannabis is used at a higher rate in PWH compared to the general population, there is interest in understanding how HIV proteins and ART drugs interact with the endocannabinoid system (ECS) and inflammation in the CNS. Therefore, we investigated the effects of the HIV envelope protein gp120 and tenofovir alafenamide (TAF) on cannabinoid receptor 1 (CB1R), glial fibrillary acidic protein (GFAP), and IBA1 in the brain and on locomotor activity in mice. The gp120 transgenic (tg) mouse model was administered TAF daily for 30 days and then analyzed using the open field test before being euthanized, and their brains were analyzed for CB1R, GFAP, and IBA1 expression using immunohistochemical approaches. CB1R expression levels were significantly increased in CA1, CA2/3, and dentate gyrus of gp120tg mice compared to wt littermates; TAF reversed these effects. As expected, TAF showed a medium effect of enhancing GFAP in the frontal cortex of gp120tg mice in the frontal cortex. TAF had minimal effect on IBA1 signal. TAF showed medium to large effects on fine movements, rearing, total activity, total distance, and lateral activity in the open-field test. These findings suggest that TAF may reverse gp120-induced effects on CB1R expression and, unlike tenofovir disoproxil fumarate (TDF), may not affect gliosis in the brain.

1 January 2017
Verified
Book Chapter
Closed access
JCJ.E. Cebak
J.E. Cebak
ISI.N. Singh
I.N. Singh
JWJ.A. Wang
J.A. Wang
RHR.L. Hill
R.L. Hill
JKJ.R. Kulbe
J.R. Kulbe
EHE.D. Hall
E.D. Hall